Benitec Biopharma Inc. (BNTC) stock
BNTCNasdaqPharmaceutical PreparationsFiscal year ends December 31
$8.15−0.39 (-4.57%)
Close on Nov 17, 2026Market cap $284.29MP/E –Yield –
Benitec Biopharma revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Benitec Biopharma's revenue for the twelve months ending Mar 31, 2025 was $0, down 100.0% year over year. For fiscal 2024 it was $0, down 100.0% from the year before. The highest annual figure on record is $12.20M in fiscal 2019.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2024 | Jun 30, 2024 | $0 | -100.0% |
| FY2023 | Jun 30, 2023 | $75.00K | +2.7% |
| FY2022 | Jun 30, 2022 | $73.00K | +23.7% |
| FY2021 | Jun 30, 2021 | $59.00K | -42.2% |
| FY2020 | Jun 30, 2020 | $102.00K | -99.2% |
| FY2019 | Jun 30, 2019 | $12.20M | – |
Quarterly revenue
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026CQ1 2026 | Mar 31, 2026 | $0 | – |
| Q2 FY2026CQ4 2025 | Dec 31, 2025 | $0 | – |
| Q1 FY2026CQ3 2025 | Sep 30, 2025 | $0 | – |
| Q3 FY2025CQ1 2025 | Mar 31, 2025 | $0 | – |
| Q2 FY2025CQ4 2024 | Dec 31, 2024 | $0 | – |
| Q1 FY2025CQ3 2024 | Sep 30, 2024 | $0 | – |
| Q4 FY2024CQ2 2024 | Jun 30, 2024 | $0 | -100.0% |
| Q3 FY2024CQ1 2024 | Mar 31, 2024 | $0 | -100.0% |
| Q2 FY2024CQ4 2023 | Dec 31, 2023 | $0 | -100.0% |
| Q1 FY2024CQ3 2023 | Sep 30, 2023 | $0 | – |
| Q4 FY2023CQ2 2023 | Jun 30, 2023 | $7.00K | – |
| Q3 FY2023CQ1 2023 | Mar 31, 2023 | $54.00K | +12.5% |
| Q2 FY2023CQ4 2022 | Dec 31, 2022 | $14.00K | -44.0% |
| Q1 FY2023CQ3 2022 | Sep 30, 2022 | $0 | – |
| Q4 FY2022CQ2 2022 | Jun 30, 2022 | $0 | -100.0% |
| Q3 FY2022CQ1 2022 | Mar 31, 2022 | $48.00K | +4700.0% |
| Q2 FY2022CQ4 2021 | Dec 31, 2021 | $25.00K | +2400.0% |
| Q1 FY2022CQ3 2021 | Sep 30, 2021 | $0 | -100.0% |
| Q4 FY2021CQ2 2021 | Jun 30, 2021 | $2.00K | -92.9% |
| Q3 FY2021CQ1 2021 | Mar 31, 2021 | $1.00K | -98.7% |
| Q2 FY2021CQ4 2020 | Dec 31, 2020 | $1.00K | -97.0% |
| Q1 FY2021CQ3 2020 | Sep 30, 2020 | $55.00K | – |
| Q3 FY2020CQ1 2020 | Mar 31, 2020 | $28.00K | – |
| Q2 FY2020CQ4 2019 | Dec 31, 2019 | $77.00K | – |
| Q1 FY2020CQ3 2019 | Sep 30, 2019 | $33.00K | – |
See a number that looks wrong?